COVID-19: specific and non-specific clinical manifestations and symptoms: the current state of knowledge
J Baj, H Karakuła-Juchnowicz, G Teresiński… - Journal of clinical …, 2020 - mdpi.com
Coronavirus disease 2019 (COVID-19), due to the severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), has become an epidemiological threat and a worldwide …
coronavirus-2 (SARS-CoV-2), has become an epidemiological threat and a worldwide …
Ultramicronized palmitoylethanolamide (um-PEA): a new possible adjuvant treatment in COVID-19 patients
The Coronavirus Disease-19 (COVID-19) pandemic has caused more than 100,000,000
cases of coronavirus infection in the world in just a year, of which there were 2 million …
cases of coronavirus infection in the world in just a year, of which there were 2 million …
Pathological findings in the postmortem liver of patients with coronavirus disease 2019 (COVID-19)
CL Zhao, A Rapkiewicz, M Maghsoodi-Deerwester… - Human pathology, 2021 - Elsevier
Summary Although coronavirus disease 2019 (COVID-19) is transmitted via respiratory
droplets, there are multiple gastrointestinal and hepatic manifestations of the disease …
droplets, there are multiple gastrointestinal and hepatic manifestations of the disease …
[HTML][HTML] Academic Textbook: Diagnosis and Treatment of Manifestations of COVID-19
The diagnosis and treatment of manifestations of COVID-19 have evolved significantly since
the onset of the pandemic. With an expanding understanding of the virus and its impact on …
the onset of the pandemic. With an expanding understanding of the virus and its impact on …
Механизмы поражения печени при COVID‑19
ТВ Пинчук, НВ Орлова, ТГ Суранова… - Медицинский …, 2020 - med-alphabet.com
Аннотация В конце 2019 года в Китае был обнаружен новый коронавирус (SARS-CoV-
2), вызывающий коронавирусную инфекцию COVID-19. Продолжающаяся пандемия …
2), вызывающий коронавирусную инфекцию COVID-19. Продолжающаяся пандемия …
Effects of Ultramicronized Palmitoylethanolamide (um-PEA) in COVID-19 Early Stages: A Case–Control Study
M Albanese, G Marrone, A Paolino, M Di Lauro… - Pharmaceuticals, 2022 - mdpi.com
Ultramicronized palmitoylethanolamide (um-PEA), a compound with antioxidant, anti-
inflammatory and neuroprotective properties, appears to be a potential adjuvant treatment …
inflammatory and neuroprotective properties, appears to be a potential adjuvant treatment …
[HTML][HTML] COVID-19 and the liver: A brief and core review
B Kayaaslan, R Guner - World Journal of Hepatology, 2021 - ncbi.nlm.nih.gov
Coronavirus disease 2019 has a wide range of clinical spectrum from asymptomatic
infection to severe infection resulting in death within a short time. Currently, it is known that …
infection to severe infection resulting in death within a short time. Currently, it is known that …
TCM “medicine and food homology” in the management of post-COVID disorders
Background The World Health Organization declared that COVID-19 is no longer a public
health emergency of global concern on May 5, 2023. Post-COVID disorders are, however …
health emergency of global concern on May 5, 2023. Post-COVID disorders are, however …
不同年龄组新型冠状病毒肺炎患者临床特征分析
耿梦杰， 任翔， 余建兴， 蒋荣猛， 李中杰， 冯子健… - 疾病监测, 2021 - jbjc.org
目的通过对不同年龄组新型冠状病毒肺炎(COVID-19) 病例发病早期的临床特征进行分析,
为及时发现和治疗管理COVID-19 患者并防止病情进展, 进一步采取有效防控措施提供参考 …
为及时发现和治疗管理COVID-19 患者并防止病情进展, 进一步采取有效防控措施提供参考 …
[HTML][HTML] Gastrointestinal complications of coronavirus disease (COVID-19)
MAF Ribeiro-Junior, SS Augusto, YGB Elias… - … Brasileiros de Cirurgia …, 2022 - SciELO Brasil
Background: It is currently understood that severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2) directly enters target cells by binding to the angiotensin-converting enzyme 2 …
(SARS-CoV-2) directly enters target cells by binding to the angiotensin-converting enzyme 2 …